“This research review highlights the transformative impact of artificial intelligence (AI) and the Internet of Things (IoT) across industriindustries, showcasing significant market growth, technological advances, and the potential for these technologies to revolutionize operations, enhance efficiency, and drive innovation.”
BOSTON, July 21, 2025 /PRNewswire/ — BCC Research announces the release of its “2024 AI & IoT Technology Research Review“. This report highlights the transformative impact of artificial intelligence (AI) and the Internet of Things (IoT) across industries, showcasing significant market growth and technological advances.
Highlights:
Research Coverage and Insights:
This research review of 2024 AI and IoT technologies focuses on how these technologies propel digital transformation, improve operational effectiveness, and open new commercial prospects globally.
Research Summary:
The 2024 Research Review of AI and IoT technology exemplifies the type of quantitative market data, analysis, and guidance that BCC Research has provided since 1971. This review includes highlights from the following reports published by BCC Research in 2024:
This Research Review provides a consolidated overview of market insights from these recent reports. The full reports referenced in this review offer additional depth on each topic, offering further context and more detailed analysis.
For further information on any of these reports or to make a purchase, contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts’ goal is to help you make informed business decisions free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo: https://healthtechnologynet.com/wp-content/uploads/2025/07/BCC_Research_Logo-3.jpg
SOURCE BCC Research LLC
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…